Repression of Arterial Genes in Hemogenic Endothelium Is Sufficient for Hematopoietic Fate Acquisition It is not known how distinct endothelial and hematopoietic fates are parsed during endothelial-to-hematopoietic transition. Scientists showed that genes required for arterial identity function later to repress hematopoietic fate. [Nat Commun] Full Article Activation of OCT4 Enhances Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem and Progenitor Cells by Regulating HOXB4 Expression Investigators present their unexpected finding that OCT4 is involved in the enhancement of cytokine-induced expansion capabilities of human cord blood hematopoietic stem cells. [Leukemia] Abstract Runx1 Repression by Histone Deacetylation Is Critical for Setbp1-Induced Mouse Myeloid Leukemia Development Scientists showed that Setbp1 overexpression in mouse bone marrow progenitors through retroviral transduction is capable of initiating leukemia development in irradiated recipient mice. [Leukemia] Abstract Mitochondrial Metabolism in Hematopoietic Stem Cells Requires Functional FOXO3 The authors identified the transcription factor FOXO3 as a new regulator of metabolic adaptation of hematopoietic stem cells (HSC). Reactive oxygen species are elevated in Foxo3-/- HSC that are defective in their activity. [EMBO Rep] Abstract PRC2 Inhibition Counteracts the Culture-Associated Loss of Engraftment Potential of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Cord blood hematopoietic stem cells (CB-HSCs) are an outstanding source for transplantation approaches. However, the amount of cells per donor is limited and culture expansion of CB-HSCs is accompanied by a loss of engraftment potential. In order to analyze the molecular mechanisms leading to this impaired potential, scientists profiled global and local epigenotypes during the expansion of human CB hematopoietic stem and progenitor cells. [Sci Rep] Full Article Fetal Hematopoietic Stem Cells Express MFG-E8 during Mouse Embryogenesis The authors investigated milk fat globule-EGF-factor 8 protein (MFG-E8) expression in multiple hematopoietic tissues at different stages of mouse embryogenesis. Using immunohistochemistry, they showed that MFG-E8 was specifically expressed in CD34+ hematopoietic stem cells at all hematopoietic sites, including the yolk sac, aorta-gonad-mesonephros region, placenta and fetal liver, during embryogenesis. [Exp Mol Med] Full Article Deficiency in Aryl Hydrocarbon Receptor (AHR) Expression throughout Aging Alters Gene Expression Profiles in Murine Long-Term Hematopoietic Stem Cells Scientists sorted the most primitive population of hematopoietic stem cells (HSCs) with the highest stem cell potential from 18-month-old AhR-null-allele (AhR-KO) and WT mice and analyzed gene expression using microarray to determine alterations in gene expression and cell signaling networks in HSCs that could potentially contribute to the aging phenotype of AhR-KO mice. [PLoS One] Full Article Hematopoietic Knockdown of PPARdδ Reduces Atherosclerosis in LDLR-/- Mice Researchers employed a microRNA approach to knock down PPARδ (peroxisome proliferator-activated receptor delta) expression in bone marrow cells followed by transplantation of the cells into LDLR-/- mice. [Gene Ther] Abstract CLINICAL RESEARCH Long-Term Sustained Disease Control in Patients with Mantle Cell Lymphoma with or without Active Disease after Treatment with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning Investigators examined the outcomes of 70 patients with mantle cell lymphoma and included extended follow-up for the 33 initial patients. Grafts were obtained from human leukocyte antigen (HLA)-matched, related donors, unrelated donors, and HLA antigen-mismatched donors. [Cancer] Abstract Favorable Outcome of Haploidentical Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Study in Southwest China Investigators analyzed the clinical outcomes of 82 Philadelphia chromosome-positive acute lymphoblastic leukemia patients who underwent haploidentical hematopoietic stem cell transplantation (HSCT) or HLA-matched HSCT. [J Hematol Oncol] Full Article Treatment with PF-04449913, an Oral Smoothened Antagonist, in Patients with Myeloid Malignancies: A Phase I Safety and Pharmacokinetics Study Investigators undertook an open-label, dose-finding, standard 3+3 design Phase I study of PF-04449913 in adult patients with acute myeloid leukemia, chronic myeloid leukemia, chronic myelomonocytic leukemia, myelodysplastic syndrome, or myelofibrosis who were refractory, resistant, or intolerant to previous treatments, at three centers in the USA and one in Italy. [Lancet Haematol] Abstract | Press Release |